With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|The Role of DNA Methylation in Pediatric Cancer||Fred Hutchinson Cancer Research Center / Scott Diede||Young Investigator Grants||2010||Washington|
|Optimizing Bispecific Antibody Therapy for Acute Leukemias||Fred Hutchinson Cancer Research Center / Roland Walter, MD, PhD & James Olson, MD, PhD||Innovation Grants||2015||Washington|
|Restoring RUNX1 Levels in FPD/AML||University of Washington, Seattle / Marshall Horwitz, MD/PhD||Familial RUNX1 Research Grants||2016||Washington|
|Immuno-therapeutic Targeting of CD56 in CBA2T3/GLIS2-AML in Children||Fred Hutchinson Cancer Research Center / Soheil Meshinchi, MD/PhD||Reach Grants||2018||Washington|
|Engineering A Graft Versus Leukemia Effect into Cord Blood Transplant for Acute Lymphoblastic Leukemia||Fred Hutchinson Cancer Research Center / Rebecca Gardner||Young Investigator Grants||2011||Washington|
|Establishing the Function of Novel MicroRNAs Associated with Resistance and Relapse in Pediatric AML||Fred Hutchinson Cancer Research Center / Vivian Oehler, MD & Soheil Meshinchi, MD/PhD||Innovation Grants||2017||Washington|
|Niche for in Vitro Generation of Hematopoietic Stem Cells from Pluripotent Stem Cells||Fred Hutchinson Cancer Research Center / Brandon Hadland, MD, PhD||Young Investigator Grants||2014||Washington|
|Exploiting the Potential of Bromodomain Inhibitors in Ewing Sarcoma||Seattle Children's Hospital / Shireen Ganapathi, MD||Young Investigator Grants||2021||Washington|
|Molecular Signature of Inflammation||Medical College of Wisconsin / Subramaniam Malarkannan, PhD||Springboard Grants||2013||Wisconsin|
|Phase I Study of Lentivirus Engineered Autologous AML Cells Expressing IL-12 in Children and Young Adults with Relapsed AML||Children's Hospital of Wisconsin - Milwaukee / Michael Burke, MD & Jeffrey Medin, MD/PhD||Reach Grants||2017||Wisconsin|